Alzheimer’s disease (AD) is the most common cause of dementia, affecting one in 10 people aged 65 years or older. The development of disease-modifying treatments for AD has largely targeted its pathological hallmarks, amyloid beta (Aβ) and tau. However, increasing evidence has shown that additional mechanisms, such as neuroinflammation, cholinergic and free radical damage, and mitochondrial dysfunction, play a role in the initiation and progression of AD.
Bon Opus offers a wide collection of research reagents to help researchers dissect the biological processes underlying AD. Useful link: Learn the latest research of Alzheimer's on nature